| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 63 | 2024 | 1017 | 6.900 |
Why?
|
| Critical Care | 65 | 2024 | 2690 | 6.550 |
Why?
|
| Status Epilepticus | 33 | 2024 | 461 | 5.580 |
Why?
|
| Brain Injuries | 38 | 2022 | 2054 | 5.270 |
Why?
|
| Critical Illness | 44 | 2022 | 2709 | 3.440 |
Why?
|
| Intracranial Pressure | 17 | 2022 | 324 | 3.320 |
Why?
|
| Brain Death | 8 | 2023 | 357 | 3.140 |
Why?
|
| Pediatrics | 30 | 2024 | 3589 | 2.570 |
Why?
|
| Intracranial Hypertension | 17 | 2023 | 193 | 2.460 |
Why?
|
| Apnea | 6 | 2020 | 195 | 2.300 |
Why?
|
| Periodicals as Topic | 8 | 2024 | 1463 | 2.260 |
Why?
|
| Craniosynostoses | 13 | 2024 | 412 | 2.200 |
Why?
|
| Anticonvulsants | 25 | 2024 | 1911 | 2.150 |
Why?
|
| Shock, Septic | 15 | 2024 | 769 | 2.120 |
Why?
|
| Child | 203 | 2024 | 80134 | 2.080 |
Why?
|
| Midazolam | 8 | 2022 | 267 | 1.830 |
Why?
|
| Respiration, Artificial | 27 | 2021 | 2630 | 1.750 |
Why?
|
| Multiple Organ Failure | 10 | 2022 | 387 | 1.620 |
Why?
|
| Writing | 3 | 2024 | 199 | 1.610 |
Why?
|
| Diabetic Ketoacidosis | 7 | 2020 | 253 | 1.590 |
Why?
|
| Cerebrovascular Circulation | 18 | 2020 | 2725 | 1.580 |
Why?
|
| Sepsis | 18 | 2024 | 2586 | 1.540 |
Why?
|
| Hypothermia, Induced | 9 | 2019 | 754 | 1.530 |
Why?
|
| Child, Preschool | 123 | 2024 | 42217 | 1.350 |
Why?
|
| Coma | 11 | 2020 | 484 | 1.350 |
Why?
|
| Hypoglycemia | 8 | 2014 | 883 | 1.330 |
Why?
|
| Delirium | 7 | 2024 | 1667 | 1.290 |
Why?
|
| Hyperglycemia | 12 | 2014 | 1375 | 1.280 |
Why?
|
| Infant | 117 | 2024 | 36164 | 1.250 |
Why?
|
| Monitoring, Physiologic | 19 | 2021 | 1780 | 1.210 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2020 | 109 | 1.100 |
Why?
|
| Humans | 326 | 2024 | 761098 | 1.080 |
Why?
|
| Seizures | 17 | 2023 | 2965 | 1.070 |
Why?
|
| Glasgow Coma Scale | 14 | 2024 | 579 | 1.040 |
Why?
|
| Brain Diseases | 7 | 2022 | 1546 | 1.020 |
Why?
|
| Brain Edema | 6 | 2014 | 604 | 0.980 |
Why?
|
| Blood Glucose | 11 | 2014 | 6390 | 0.910 |
Why?
|
| Respiratory Insufficiency | 13 | 2022 | 1231 | 0.900 |
Why?
|
| Hypnotics and Sedatives | 4 | 2018 | 1178 | 0.880 |
Why?
|
| Hydrocortisone | 5 | 2015 | 1818 | 0.860 |
Why?
|
| Heart Arrest | 7 | 2017 | 1514 | 0.860 |
Why?
|
| Benzodiazepines | 10 | 2024 | 1134 | 0.860 |
Why?
|
| Pentobarbital | 3 | 2022 | 153 | 0.850 |
Why?
|
| Infant, Newborn | 60 | 2024 | 26187 | 0.820 |
Why?
|
| Diagnostic Techniques, Neurological | 2 | 2020 | 62 | 0.800 |
Why?
|
| Cholinergic Antagonists | 3 | 2021 | 167 | 0.790 |
Why?
|
| Neurology | 6 | 2023 | 784 | 0.790 |
Why?
|
| High-Frequency Ventilation | 5 | 2008 | 88 | 0.780 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2020 | 1462 | 0.780 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 138 | 0.770 |
Why?
|
| Brain | 16 | 2022 | 27097 | 0.740 |
Why?
|
| Brain Concussion | 3 | 2019 | 1404 | 0.740 |
Why?
|
| Epinephrine | 2 | 2015 | 792 | 0.730 |
Why?
|
| Central Nervous System Diseases | 5 | 2020 | 521 | 0.720 |
Why?
|
| Cholinesterases | 1 | 2020 | 32 | 0.720 |
Why?
|
| Unconsciousness | 2 | 2020 | 249 | 0.710 |
Why?
|
| Paralysis | 1 | 2022 | 250 | 0.710 |
Why?
|
| Electroencephalography | 20 | 2024 | 6242 | 0.710 |
Why?
|
| Catastrophic Illness | 1 | 2020 | 60 | 0.700 |
Why?
|
| Adolescent | 92 | 2024 | 88271 | 0.700 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2017 | 993 | 0.700 |
Why?
|
| Clinical Protocols | 7 | 2022 | 1436 | 0.680 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2008 | 365 | 0.680 |
Why?
|
| Hospital Mortality | 14 | 2022 | 5296 | 0.680 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 4 | 2020 | 281 | 0.670 |
Why?
|
| Craniocerebral Trauma | 6 | 2006 | 490 | 0.650 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 176 | 0.650 |
Why?
|
| Shock | 2 | 2015 | 314 | 0.640 |
Why?
|
| Anesthesia, General | 3 | 2017 | 1174 | 0.630 |
Why?
|
| Nervous System Diseases | 4 | 2022 | 1663 | 0.630 |
Why?
|
| Bioethical Issues | 1 | 2020 | 120 | 0.630 |
Why?
|
| Blood Flow Velocity | 4 | 2019 | 1374 | 0.620 |
Why?
|
| Fluid Therapy | 9 | 2020 | 578 | 0.610 |
Why?
|
| Carbon Dioxide | 7 | 2020 | 1148 | 0.610 |
Why?
|
| Polyneuropathies | 1 | 2019 | 137 | 0.600 |
Why?
|
| Barbiturates | 4 | 2019 | 113 | 0.600 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 233 | 0.600 |
Why?
|
| Patient Selection | 6 | 2019 | 4245 | 0.590 |
Why?
|
| Decompressive Craniectomy | 4 | 2020 | 76 | 0.590 |
Why?
|
| Hyperoxia | 1 | 2020 | 258 | 0.590 |
Why?
|
| Research Report | 1 | 2021 | 367 | 0.580 |
Why?
|
| S100 Proteins | 2 | 2009 | 216 | 0.570 |
Why?
|
| Somatotrophs | 1 | 2017 | 2 | 0.570 |
Why?
|
| Bronchiolitis, Viral | 2 | 2008 | 82 | 0.560 |
Why?
|
| Oxygen | 10 | 2020 | 4226 | 0.550 |
Why?
|
| Trauma Severity Indices | 3 | 2014 | 478 | 0.550 |
Why?
|
| Hypopituitarism | 3 | 2007 | 250 | 0.550 |
Why?
|
| Cerebral Veins | 1 | 2018 | 157 | 0.550 |
Why?
|
| Consciousness Disorders | 2 | 2020 | 441 | 0.540 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 570 | 0.540 |
Why?
|
| Drowning | 1 | 2016 | 26 | 0.540 |
Why?
|
| Off-Label Use | 1 | 2018 | 185 | 0.540 |
Why?
|
| Glucose Clamp Technique | 1 | 2017 | 262 | 0.530 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 172 | 0.530 |
Why?
|
| Practice Guidelines as Topic | 17 | 2020 | 7400 | 0.530 |
Why?
|
| Headache Disorders | 1 | 2018 | 152 | 0.520 |
Why?
|
| Diazepam | 3 | 2023 | 215 | 0.520 |
Why?
|
| Intensive Care, Neonatal | 6 | 2018 | 199 | 0.520 |
Why?
|
| Male | 125 | 2024 | 360675 | 0.510 |
Why?
|
| Neuroprotective Agents | 3 | 2016 | 956 | 0.500 |
Why?
|
| Ischemic Attack, Transient | 3 | 2015 | 874 | 0.490 |
Why?
|
| Neurosecretory Systems | 2 | 2008 | 223 | 0.490 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 564 | 0.490 |
Why?
|
| Head | 3 | 2017 | 922 | 0.480 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2015 | 177 | 0.480 |
Why?
|
| Bronchiolitis | 3 | 2013 | 485 | 0.470 |
Why?
|
| Female | 118 | 2024 | 392458 | 0.470 |
Why?
|
| Disclosure | 1 | 2020 | 747 | 0.460 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 705 | 0.450 |
Why?
|
| Homeostasis | 5 | 2019 | 3318 | 0.450 |
Why?
|
| Cerebral Cortex | 6 | 2021 | 5777 | 0.450 |
Why?
|
| Sodium Chloride | 3 | 2013 | 584 | 0.450 |
Why?
|
| Movement Disorders | 2 | 2017 | 459 | 0.450 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.450 |
Why?
|
| Informed Consent | 2 | 2017 | 1007 | 0.450 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 61 | 0.450 |
Why?
|
| England | 11 | 2014 | 526 | 0.440 |
Why?
|
| Neurosurgery | 2 | 2019 | 679 | 0.440 |
Why?
|
| Mannitol | 1 | 2014 | 177 | 0.440 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2014 | 114 | 0.440 |
Why?
|
| Hypoglycemic Agents | 6 | 2017 | 3086 | 0.430 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 304 | 0.430 |
Why?
|
| Intubation, Intratracheal | 5 | 2013 | 1331 | 0.430 |
Why?
|
| Patient Positioning | 1 | 2016 | 326 | 0.430 |
Why?
|
| Hemodynamics | 8 | 2020 | 4164 | 0.430 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 962 | 0.420 |
Why?
|
| Anastomosis, Surgical | 2 | 2015 | 982 | 0.420 |
Why?
|
| Child Development | 2 | 2016 | 2302 | 0.420 |
Why?
|
| Insulin | 9 | 2017 | 6588 | 0.420 |
Why?
|
| Brain Damage, Chronic | 3 | 2005 | 266 | 0.420 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2013 | 58 | 0.420 |
Why?
|
| Intensive Care Units | 11 | 2022 | 3743 | 0.410 |
Why?
|
| Hydrodynamics | 1 | 2013 | 168 | 0.410 |
Why?
|
| Bayes Theorem | 3 | 2019 | 2327 | 0.410 |
Why?
|
| Drug Utilization | 1 | 2018 | 1188 | 0.400 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 624 | 0.400 |
Why?
|
| Moyamoya Disease | 1 | 2015 | 265 | 0.400 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 981 | 0.400 |
Why?
|
| Brain Ischemia | 7 | 2015 | 3031 | 0.400 |
Why?
|
| Glycemic Index | 3 | 2011 | 396 | 0.400 |
Why?
|
| Patient Discharge | 3 | 2019 | 3441 | 0.400 |
Why?
|
| Coronary Care Units | 1 | 2013 | 235 | 0.390 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 704 | 0.390 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2009 | 126 | 0.390 |
Why?
|
| Health Status Indicators | 1 | 2017 | 970 | 0.390 |
Why?
|
| Infusions, Intravenous | 7 | 2020 | 2217 | 0.380 |
Why?
|
| Anesthetics, Intravenous | 1 | 2014 | 394 | 0.380 |
Why?
|
| Stroke | 5 | 2020 | 9720 | 0.370 |
Why?
|
| Hypovolemia | 3 | 2006 | 48 | 0.370 |
Why?
|
| Attitude | 1 | 2016 | 772 | 0.370 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 259 | 0.370 |
Why?
|
| Models, Biological | 4 | 2018 | 9455 | 0.370 |
Why?
|
| Vasoconstrictor Agents | 5 | 2020 | 654 | 0.360 |
Why?
|
| Blood Pressure | 9 | 2019 | 8478 | 0.360 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2010 | 4 | 0.360 |
Why?
|
| Neuroimmunomodulation | 3 | 2018 | 184 | 0.350 |
Why?
|
| Body Temperature | 1 | 2013 | 780 | 0.350 |
Why?
|
| Croup | 2 | 2003 | 23 | 0.350 |
Why?
|
| Hypotension | 3 | 2014 | 879 | 0.350 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 15845 | 0.350 |
Why?
|
| Organ Transplantation | 1 | 2020 | 1164 | 0.350 |
Why?
|
| Nitric Oxide | 9 | 2002 | 2135 | 0.340 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1162 | 0.340 |
Why?
|
| Perfusion | 1 | 2014 | 1390 | 0.330 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 35 | 0.330 |
Why?
|
| Mountaineering | 1 | 2009 | 45 | 0.320 |
Why?
|
| Enteral Nutrition | 3 | 2021 | 794 | 0.320 |
Why?
|
| Epilepsy | 3 | 2021 | 3304 | 0.310 |
Why?
|
| Prosencephalon | 1 | 2010 | 305 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2022 | 10213 | 0.310 |
Why?
|
| Resuscitation | 4 | 2020 | 672 | 0.310 |
Why?
|
| Infant, Premature | 3 | 2016 | 2106 | 0.300 |
Why?
|
| Hyperventilation | 3 | 2005 | 78 | 0.300 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1893 | 0.300 |
Why?
|
| Oxyhemoglobins | 1 | 2009 | 212 | 0.300 |
Why?
|
| Cognition Disorders | 3 | 2012 | 3974 | 0.300 |
Why?
|
| Prospective Studies | 34 | 2021 | 54419 | 0.290 |
Why?
|
| Altitude | 1 | 2009 | 163 | 0.290 |
Why?
|
| Intelligence | 1 | 2012 | 922 | 0.290 |
Why?
|
| Posture | 1 | 2012 | 956 | 0.290 |
Why?
|
| Corpus Callosum | 2 | 2022 | 750 | 0.290 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 943 | 0.290 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 485 | 0.280 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2016 | 339 | 0.280 |
Why?
|
| Meningitis, Meningococcal | 1 | 2007 | 43 | 0.280 |
Why?
|
| Hippocampus | 7 | 2006 | 3757 | 0.280 |
Why?
|
| Positive-Pressure Respiration | 4 | 1999 | 638 | 0.280 |
Why?
|
| Biomedical Research | 3 | 2020 | 3429 | 0.280 |
Why?
|
| Patient Transfer | 4 | 2010 | 793 | 0.270 |
Why?
|
| Models, Statistical | 3 | 2017 | 5077 | 0.270 |
Why?
|
| Retrospective Studies | 37 | 2024 | 80673 | 0.270 |
Why?
|
| Hospitals | 2 | 2020 | 3881 | 0.270 |
Why?
|
| Perioperative Care | 1 | 2014 | 1037 | 0.260 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2008 | 279 | 0.260 |
Why?
|
| Pulmonary Gas Exchange | 5 | 2014 | 379 | 0.260 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1406 | 0.260 |
Why?
|
| Retinal Hemorrhage | 2 | 2004 | 95 | 0.260 |
Why?
|
| Encephalocele | 2 | 2020 | 135 | 0.260 |
Why?
|
| Hypothalamic Diseases | 1 | 2007 | 134 | 0.250 |
Why?
|
| Migraine Disorders | 1 | 2018 | 1701 | 0.250 |
Why?
|
| Diffuse Axonal Injury | 1 | 2006 | 49 | 0.250 |
Why?
|
| Energy Metabolism | 5 | 2014 | 2877 | 0.250 |
Why?
|
| Acrocephalosyndactylia | 2 | 2021 | 91 | 0.250 |
Why?
|
| Hematoma, Subdural | 2 | 2004 | 127 | 0.250 |
Why?
|
| Lymphopenia | 2 | 2004 | 281 | 0.250 |
Why?
|
| Child Mortality | 2 | 2014 | 199 | 0.250 |
Why?
|
| Ambulances | 1 | 2005 | 91 | 0.250 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2021 | 575 | 0.250 |
Why?
|
| Adrenal Insufficiency | 1 | 2007 | 194 | 0.240 |
Why?
|
| Ferritins | 1 | 2007 | 597 | 0.240 |
Why?
|
| Death | 3 | 2020 | 675 | 0.240 |
Why?
|
| Length of Stay | 9 | 2020 | 6420 | 0.240 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3882 | 0.240 |
Why?
|
| Polysomnography | 5 | 2024 | 1848 | 0.240 |
Why?
|
| Encephalitis | 2 | 2018 | 439 | 0.230 |
Why?
|
| Phenotype | 3 | 2022 | 16572 | 0.230 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 2003 | 8 | 0.230 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 1999 | 80 | 0.220 |
Why?
|
| Anesthesiology | 1 | 2014 | 1121 | 0.220 |
Why?
|
| Pulmonary Medicine | 1 | 2006 | 221 | 0.220 |
Why?
|
| Battered Child Syndrome | 1 | 2003 | 11 | 0.220 |
Why?
|
| Growth Hormone | 1 | 2005 | 569 | 0.220 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 1386 | 0.220 |
Why?
|
| Wales | 4 | 2010 | 87 | 0.210 |
Why?
|
| Hemostasis | 1 | 2006 | 470 | 0.210 |
Why?
|
| Hemoglobins | 1 | 2009 | 1525 | 0.210 |
Why?
|
| Isotonic Solutions | 4 | 2006 | 117 | 0.210 |
Why?
|
| Acute Disease | 11 | 2017 | 7240 | 0.210 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 1995 | 242 | 0.210 |
Why?
|
| Treatment Outcome | 27 | 2021 | 64670 | 0.210 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2004 | 127 | 0.210 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 3689 | 0.210 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2024 | 1874 | 0.210 |
Why?
|
| Prolactin | 1 | 2004 | 625 | 0.200 |
Why?
|
| Skull | 2 | 2005 | 818 | 0.200 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1216 | 0.200 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1474 | 0.200 |
Why?
|
| Hospitalization | 12 | 2018 | 10712 | 0.200 |
Why?
|
| Hematology | 1 | 2006 | 243 | 0.200 |
Why?
|
| Life Support Care | 2 | 2011 | 225 | 0.200 |
Why?
|
| Cohort Studies | 12 | 2021 | 41486 | 0.200 |
Why?
|
| Time Factors | 22 | 2021 | 39953 | 0.200 |
Why?
|
| History, 20th Century | 2 | 2024 | 2764 | 0.200 |
Why?
|
| Masks | 1 | 2003 | 208 | 0.190 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2002 | 106 | 0.180 |
Why?
|
| Peer Review | 1 | 2023 | 217 | 0.180 |
Why?
|
| Papilledema | 2 | 2016 | 130 | 0.180 |
Why?
|
| Anesthetics, Inhalation | 2 | 2017 | 572 | 0.180 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2001 | 106 | 0.180 |
Why?
|
| Pilot Projects | 4 | 2018 | 8639 | 0.180 |
Why?
|
| Emergency Treatment | 2 | 2018 | 495 | 0.180 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 619 | 0.180 |
Why?
|
| Seizures, Febrile | 1 | 2021 | 108 | 0.170 |
Why?
|
| Consensus | 5 | 2020 | 3133 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2010 | 2981 | 0.170 |
Why?
|
| Research Design | 7 | 2022 | 6178 | 0.170 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 951 | 0.170 |
Why?
|
| Respiration Disorders | 2 | 2004 | 366 | 0.170 |
Why?
|
| Withholding Treatment | 2 | 2011 | 616 | 0.170 |
Why?
|
| Statistics, Nonparametric | 5 | 2018 | 2855 | 0.170 |
Why?
|
| Albumins | 1 | 2002 | 575 | 0.160 |
Why?
|
| Hospitals, Pediatric | 6 | 2020 | 1860 | 0.160 |
Why?
|
| Dantrolene | 1 | 1998 | 26 | 0.160 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 14676 | 0.160 |
Why?
|
| Serum Albumin | 1 | 2002 | 674 | 0.160 |
Why?
|
| Emergency Service, Hospital | 5 | 2017 | 7873 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3114 | 0.160 |
Why?
|
| Animals, Newborn | 3 | 2016 | 2666 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1521 | 0.160 |
Why?
|
| United States | 11 | 2020 | 72337 | 0.160 |
Why?
|
| Bioethics | 1 | 2020 | 117 | 0.160 |
Why?
|
| Achondroplasia | 1 | 1998 | 28 | 0.160 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2018 | 25 | 0.150 |
Why?
|
| Photoperiod | 1 | 2019 | 139 | 0.150 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2018 | 38 | 0.150 |
Why?
|
| Erythrocyte Count | 1 | 2018 | 157 | 0.150 |
Why?
|
| Hepatic Encephalopathy | 1 | 2019 | 143 | 0.150 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 273 | 0.150 |
Why?
|
| Decision Making | 4 | 2018 | 3925 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2024 | 1566 | 0.150 |
Why?
|
| Hypertonic Solutions | 3 | 2004 | 82 | 0.150 |
Why?
|
| Acetylcholine | 1 | 2020 | 629 | 0.150 |
Why?
|
| Plasma Substitutes | 3 | 2004 | 57 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2024 | 10755 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2015 | 977 | 0.150 |
Why?
|
| Cytokines | 3 | 2017 | 7386 | 0.150 |
Why?
|
| Respiratory Tract Infections | 2 | 2003 | 1009 | 0.150 |
Why?
|
| Neurotoxins | 3 | 1995 | 240 | 0.150 |
Why?
|
| Feeding Methods | 1 | 2017 | 35 | 0.150 |
Why?
|
| Rehydration Solutions | 3 | 2004 | 43 | 0.150 |
Why?
|
| Centralized Hospital Services | 1 | 1997 | 18 | 0.150 |
Why?
|
| Bed Occupancy | 1 | 1997 | 38 | 0.150 |
Why?
|
| Reperfusion | 1 | 1998 | 271 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2019 | 181 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 9025 | 0.140 |
Why?
|
| Brain Stem | 2 | 2020 | 858 | 0.140 |
Why?
|
| Emergencies | 3 | 2016 | 1217 | 0.140 |
Why?
|
| Moral Development | 1 | 2016 | 13 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2001 | 894 | 0.140 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2018 | 304 | 0.140 |
Why?
|
| ROC Curve | 4 | 2014 | 3582 | 0.140 |
Why?
|
| Parents | 2 | 2014 | 3564 | 0.140 |
Why?
|
| Postoperative Complications | 7 | 2014 | 15634 | 0.140 |
Why?
|
| Inflammation | 1 | 2017 | 10758 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 232 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 426 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1400 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 1878 | 0.140 |
Why?
|
| Parenteral Nutrition | 2 | 2018 | 659 | 0.140 |
Why?
|
| Meningitis | 1 | 1998 | 217 | 0.130 |
Why?
|
| Prognosis | 14 | 2022 | 29672 | 0.130 |
Why?
|
| Leptin | 1 | 2004 | 1595 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2019 | 412 | 0.130 |
Why?
|
| Young Adult | 12 | 2021 | 59199 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 126 | 0.130 |
Why?
|
| Intracranial Hemorrhages | 2 | 2017 | 809 | 0.130 |
Why?
|
| Dizocilpine Maleate | 2 | 1994 | 172 | 0.130 |
Why?
|
| Snoring | 1 | 2017 | 209 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2018 | 254 | 0.130 |
Why?
|
| Myasthenia Gravis | 1 | 1998 | 214 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2016 | 180 | 0.130 |
Why?
|
| Supine Position | 1 | 2016 | 205 | 0.120 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1995 | 41 | 0.120 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 413 | 0.120 |
Why?
|
| Lung | 5 | 2016 | 9979 | 0.120 |
Why?
|
| Lidocaine | 1 | 2018 | 538 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2016 | 193 | 0.120 |
Why?
|
| Medical Futility | 1 | 1996 | 136 | 0.120 |
Why?
|
| Altitude Sickness | 1 | 2016 | 91 | 0.120 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1995 | 30 | 0.120 |
Why?
|
| Acute Kidney Injury | 3 | 2006 | 1923 | 0.120 |
Why?
|
| Tetrodotoxin | 2 | 1994 | 245 | 0.120 |
Why?
|
| Pertussis Vaccine | 1 | 1994 | 39 | 0.120 |
Why?
|
| Palliative Care | 2 | 2010 | 3593 | 0.120 |
Why?
|
| Neurons | 4 | 2012 | 9435 | 0.120 |
Why?
|
| Internationality | 1 | 2020 | 1000 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 415 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2012 | 20600 | 0.120 |
Why?
|
| Adult | 21 | 2023 | 221083 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 1998 | 547 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 619 | 0.120 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 539 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 347 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 8000 | 0.120 |
Why?
|
| Pulmonary Surfactants | 1 | 1995 | 162 | 0.120 |
Why?
|
| Brazil | 2 | 2011 | 1229 | 0.120 |
Why?
|
| Abdomen | 1 | 2020 | 1128 | 0.120 |
Why?
|
| Cell Enlargement | 1 | 2014 | 59 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 1996 | 386 | 0.120 |
Why?
|
| Bereavement | 2 | 2018 | 309 | 0.110 |
Why?
|
| Follow-Up Studies | 10 | 2023 | 39121 | 0.110 |
Why?
|
| Logistic Models | 4 | 2008 | 13254 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2002 | 1246 | 0.110 |
Why?
|
| Risk Factors | 11 | 2020 | 74219 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2005 | 2478 | 0.110 |
Why?
|
| Hypercapnia | 1 | 1995 | 261 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1921 | 0.110 |
Why?
|
| Immunization, Secondary | 2 | 1999 | 366 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1997 | 326 | 0.110 |
Why?
|
| Bronchi | 1 | 1997 | 843 | 0.110 |
Why?
|
| Receptors, Amino Acid | 1 | 1992 | 30 | 0.110 |
Why?
|
| Syndrome | 5 | 2020 | 3269 | 0.110 |
Why?
|
| Severe Acute Respiratory Syndrome | 2 | 2004 | 137 | 0.110 |
Why?
|
| Feedback | 1 | 2017 | 790 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 913 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 787 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 555 | 0.100 |
Why?
|
| India | 1 | 2019 | 2287 | 0.100 |
Why?
|
| Education, Medical, Graduate | 2 | 2006 | 2372 | 0.100 |
Why?
|
| Neurologic Examination | 3 | 2023 | 915 | 0.100 |
Why?
|
| Hernia, Umbilical | 1 | 1993 | 102 | 0.100 |
Why?
|
| Health Care Costs | 3 | 2014 | 3238 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12058 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 2 | 2023 | 2923 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20120 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1996 | 514 | 0.100 |
Why?
|
| Medical Errors | 1 | 2000 | 1263 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 1376 | 0.100 |
Why?
|
| Trachea | 2 | 1997 | 1090 | 0.100 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 642 | 0.100 |
Why?
|
| Guideline Adherence | 2 | 2020 | 2218 | 0.100 |
Why?
|
| Conscious Sedation | 1 | 2016 | 533 | 0.090 |
Why?
|
| Analgesia | 1 | 2016 | 461 | 0.090 |
Why?
|
| Neonatology | 1 | 2013 | 140 | 0.090 |
Why?
|
| Isoflurane | 1 | 2014 | 384 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36418 | 0.090 |
Why?
|
| Administration, Inhalation | 7 | 2002 | 1157 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2016 | 719 | 0.090 |
Why?
|
| Analysis of Variance | 6 | 2017 | 6224 | 0.090 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1991 | 38 | 0.090 |
Why?
|
| Nausea | 1 | 2014 | 679 | 0.090 |
Why?
|
| Ventilator Weaning | 3 | 2010 | 164 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3319 | 0.090 |
Why?
|
| Hemangioma | 1 | 1996 | 727 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2081 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 773 | 0.090 |
Why?
|
| Quality of Life | 4 | 2022 | 13362 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 75 | 0.080 |
Why?
|
| Thiopental | 1 | 1989 | 55 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 12975 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2424 | 0.080 |
Why?
|
| Rats | 8 | 2016 | 23713 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 5070 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1932 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2014 | 845 | 0.080 |
Why?
|
| Anemia | 1 | 2018 | 1504 | 0.080 |
Why?
|
| Ketamine | 1 | 2014 | 517 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2007 | 6343 | 0.080 |
Why?
|
| Drug Design | 1 | 2013 | 1045 | 0.080 |
Why?
|
| Argentina | 1 | 2009 | 246 | 0.080 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 426 | 0.080 |
Why?
|
| Pituitary Gland | 2 | 2008 | 635 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 278 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 3808 | 0.070 |
Why?
|
| Culture Techniques | 3 | 2001 | 531 | 0.070 |
Why?
|
| Craniofacial Dysostosis | 1 | 2008 | 74 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1067 | 0.070 |
Why?
|
| Spasms, Infantile | 1 | 1991 | 298 | 0.070 |
Why?
|
| Complementary Therapies | 1 | 2011 | 486 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 1027 | 0.070 |
Why?
|
| Disease Progression | 1 | 2024 | 13506 | 0.070 |
Why?
|
| Aging | 2 | 2004 | 8701 | 0.070 |
Why?
|
| Phosphocreatine | 2 | 2000 | 261 | 0.070 |
Why?
|
| Sleep Stages | 2 | 2024 | 695 | 0.070 |
Why?
|
| Bronchodilator Agents | 2 | 2002 | 512 | 0.070 |
Why?
|
| Respiratory System Agents | 2 | 1997 | 30 | 0.070 |
Why?
|
| Radiography | 2 | 2014 | 6975 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 367 | 0.070 |
Why?
|
| Europe | 4 | 2013 | 3422 | 0.070 |
Why?
|
| Risk Adjustment | 1 | 2010 | 601 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4813 | 0.070 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 2055 | 0.070 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2006 | 20 | 0.070 |
Why?
|
| Shaken Baby Syndrome | 2 | 2004 | 24 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4849 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6305 | 0.070 |
Why?
|
| Whooping Cough | 2 | 1999 | 86 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 2401 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1341 | 0.070 |
Why?
|
| Patient Admission | 2 | 2015 | 1365 | 0.070 |
Why?
|
| Bicarbonates | 2 | 2005 | 292 | 0.070 |
Why?
|
| Poverty Areas | 3 | 2018 | 263 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1996 | 2160 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2014 | 1490 | 0.070 |
Why?
|
| Diagnosis-Related Groups | 2 | 1998 | 448 | 0.070 |
Why?
|
| Hyponatremia | 1 | 2009 | 279 | 0.070 |
Why?
|
| Microcirculation | 1 | 2011 | 1280 | 0.070 |
Why?
|
| State Medicine | 1 | 2007 | 216 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2075 | 0.060 |
Why?
|
| Ireland | 3 | 2015 | 169 | 0.060 |
Why?
|
| Transportation of Patients | 2 | 2018 | 174 | 0.060 |
Why?
|
| Heart Rate | 1 | 2017 | 4196 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2011 | 875 | 0.060 |
Why?
|
| Cerebral Arteries | 1 | 1988 | 490 | 0.060 |
Why?
|
| Child Behavior | 1 | 2011 | 848 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2017 | 6385 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1549 | 0.060 |
Why?
|
| Burnout, Professional | 1 | 2014 | 703 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2007 | 566 | 0.060 |
Why?
|
| Oximetry | 1 | 2009 | 459 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1923 | 0.060 |
Why?
|
| Societies, Medical | 3 | 2023 | 3923 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 354 | 0.060 |
Why?
|
| Reference Standards | 1 | 2009 | 1005 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 618 | 0.060 |
Why?
|
| Patient Care Team | 4 | 2011 | 2513 | 0.060 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2004 | 18 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1213 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2005 | 141 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3598 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 181 | 0.060 |
Why?
|
| Risk | 2 | 2007 | 9614 | 0.060 |
Why?
|
| Social Support | 1 | 2014 | 2175 | 0.060 |
Why?
|
| Sleep | 2 | 2017 | 4761 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2006 | 773 | 0.060 |
Why?
|
| N-Methylaspartate | 3 | 1995 | 230 | 0.060 |
Why?
|
| Diffusion | 1 | 2005 | 813 | 0.050 |
Why?
|
| Hormones | 1 | 2007 | 869 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3094 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 2002 | 658 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3216 | 0.050 |
Why?
|
| Kenya | 2 | 2018 | 756 | 0.050 |
Why?
|
| Heart | 1 | 2016 | 4431 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1187 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 1993 | 1585 | 0.050 |
Why?
|
| Cross Infection | 2 | 2004 | 1422 | 0.050 |
Why?
|
| Colloids | 1 | 2002 | 123 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 751 | 0.050 |
Why?
|
| Airway Obstruction | 2 | 1998 | 660 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2005 | 3422 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1301 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2004 | 282 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2000 | 1987 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2005 | 495 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2012 | 1966 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2006 | 630 | 0.050 |
Why?
|
| Plastics | 1 | 2022 | 117 | 0.050 |
Why?
|
| Medical Audit | 3 | 2009 | 453 | 0.050 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2021 | 38 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 747 | 0.050 |
Why?
|
| Diuretics, Osmotic | 1 | 2001 | 33 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2003 | 579 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2021 | 7969 | 0.050 |
Why?
|
| Survival Rate | 5 | 2005 | 12727 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5494 | 0.050 |
Why?
|
| Dura Mater | 1 | 2003 | 290 | 0.050 |
Why?
|
| Glutamates | 2 | 1992 | 385 | 0.050 |
Why?
|
| Atrophy | 1 | 2006 | 1633 | 0.040 |
Why?
|
| Energy Intake | 2 | 2021 | 2133 | 0.040 |
Why?
|
| Research | 2 | 2006 | 1975 | 0.040 |
Why?
|
| France | 1 | 2011 | 492 | 0.040 |
Why?
|
| Iron | 1 | 2009 | 1790 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5249 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2023 | 339 | 0.040 |
Why?
|
| Syringomyelia | 1 | 2020 | 67 | 0.040 |
Why?
|
| Phenytoin | 1 | 2020 | 190 | 0.040 |
Why?
|
| Cadaver | 2 | 2022 | 1358 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6987 | 0.040 |
Why?
|
| Phenobarbital | 1 | 2020 | 191 | 0.040 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 526 | 0.040 |
Why?
|
| Glutamic Acid | 3 | 1995 | 1173 | 0.040 |
Why?
|
| Hospice Care | 2 | 2010 | 677 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 702 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 387 | 0.040 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 178 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 22157 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 1998 | 32 | 0.040 |
Why?
|
| Algorithms | 5 | 2020 | 14023 | 0.040 |
Why?
|
| Pulmonary Heart Disease | 1 | 1998 | 34 | 0.040 |
Why?
|
| Anisotropy | 1 | 2022 | 1284 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2004 | 936 | 0.040 |
Why?
|
| Adenoids | 1 | 1998 | 35 | 0.040 |
Why?
|
| Acidosis, Respiratory | 1 | 1998 | 37 | 0.040 |
Why?
|
| Viscera | 1 | 1999 | 138 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 237 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2022 | 571 | 0.040 |
Why?
|
| Ion Transport | 1 | 1999 | 320 | 0.040 |
Why?
|
| Prevalence | 4 | 2020 | 15717 | 0.040 |
Why?
|
| Edema | 1 | 2002 | 765 | 0.040 |
Why?
|
| Convalescence | 1 | 1998 | 106 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 1998 | 193 | 0.040 |
Why?
|
| Apoptosis | 2 | 2004 | 9478 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 663 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2000 | 3770 | 0.040 |
Why?
|
| Victoria | 1 | 1997 | 64 | 0.040 |
Why?
|
| Peer Group | 1 | 2023 | 691 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1255 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2787 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 1450 | 0.040 |
Why?
|
| Scotland | 1 | 1997 | 143 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3367 | 0.040 |
Why?
|
| Clinical Competence | 2 | 2005 | 4786 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2015 | 2278 | 0.040 |
Why?
|
| Respiration | 2 | 2021 | 1656 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 4340 | 0.040 |
Why?
|
| Ghana | 1 | 2018 | 315 | 0.040 |
Why?
|
| Age Factors | 4 | 2020 | 18385 | 0.030 |
Why?
|
| Hyperemia | 1 | 1998 | 225 | 0.030 |
Why?
|
| Meningococcal Infections | 1 | 1997 | 77 | 0.030 |
Why?
|
| Immunization | 1 | 2001 | 1218 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 7043 | 0.030 |
Why?
|
| Age Distribution | 2 | 2015 | 2873 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 1999 | 381 | 0.030 |
Why?
|
| Animals | 12 | 2018 | 168083 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1998 | 558 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4583 | 0.030 |
Why?
|
| London | 1 | 1996 | 233 | 0.030 |
Why?
|
| Incidence | 3 | 2015 | 21357 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 461 | 0.030 |
Why?
|
| Sex Factors | 2 | 2020 | 10552 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 1997 | 250 | 0.030 |
Why?
|
| Immunization Programs | 1 | 1999 | 267 | 0.030 |
Why?
|
| Aortic Valve | 1 | 1986 | 1959 | 0.030 |
Why?
|
| Epoetin Alfa | 1 | 2016 | 78 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 2001 | 804 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1997 | 393 | 0.030 |
Why?
|
| Rett Syndrome | 1 | 1997 | 163 | 0.030 |
Why?
|
| Rwanda | 1 | 2018 | 660 | 0.030 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 144 | 0.030 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1995 | 21 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3210 | 0.030 |
Why?
|
| Child Abuse | 1 | 2004 | 1076 | 0.030 |
Why?
|
| Taurine | 1 | 1996 | 92 | 0.030 |
Why?
|
| Health Surveys | 2 | 2013 | 4036 | 0.030 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 477 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 1994 | 333 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2015 | 24013 | 0.030 |
Why?
|
| Calpain | 1 | 2016 | 146 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 1998 | 408 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1999 | 1866 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 1664 | 0.030 |
Why?
|
| Linear Models | 1 | 2005 | 5869 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1997 | 288 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 1995 | 91 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1997 | 446 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 1996 | 201 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1998 | 1150 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2022 | 5971 | 0.030 |
Why?
|
| Respiratory System | 1 | 1998 | 562 | 0.030 |
Why?
|
| Depersonalization | 1 | 2014 | 39 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1996 | 330 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1998 | 1768 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2020 | 1139 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 991 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1997 | 462 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 550 | 0.030 |
Why?
|
| Treatment Failure | 2 | 1999 | 2643 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2013 | 3603 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2014 | 73 | 0.030 |
Why?
|
| Glucose | 2 | 1998 | 4341 | 0.030 |
Why?
|
| Tracheal Stenosis | 1 | 1996 | 228 | 0.030 |
Why?
|
| Cephalometry | 1 | 2015 | 382 | 0.030 |
Why?
|
| Home Care Services | 1 | 2010 | 647 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2014 | 174 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 240 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 1999 | 739 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 335 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1618 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 2 | 1999 | 561 | 0.030 |
Why?
|
| Esophageal Atresia | 1 | 1996 | 224 | 0.030 |
Why?
|
| Symporters | 1 | 2016 | 363 | 0.030 |
Why?
|
| Achievement | 1 | 2014 | 288 | 0.030 |
Why?
|
| Benzamides | 1 | 1998 | 1370 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2656 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 80 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 983 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 709 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1992 | 193 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1995 | 555 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1535 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1033 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2014 | 432 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1995 | 563 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2020 | 2024 | 0.020 |
Why?
|
| Stomach | 1 | 1996 | 697 | 0.020 |
Why?
|
| Potassium | 1 | 1996 | 1309 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1510 | 0.020 |
Why?
|
| Kainic Acid | 1 | 1991 | 203 | 0.020 |
Why?
|
| Synapses | 1 | 2001 | 1755 | 0.020 |
Why?
|
| Blood Pressure Monitors | 1 | 1991 | 33 | 0.020 |
Why?
|
| Decompression, Surgical | 2 | 2008 | 607 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 1991 | 51 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2001 | 10083 | 0.020 |
Why?
|
| Brain Mapping | 2 | 2005 | 6635 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1813 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1577 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12467 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1992 | 574 | 0.020 |
Why?
|
| Family Health | 1 | 1994 | 1255 | 0.020 |
Why?
|
| Terminal Care | 1 | 2011 | 1755 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3335 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1995 | 976 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 920 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 5427 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 1996 | 821 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1702 | 0.020 |
Why?
|
| Partial Pressure | 2 | 1999 | 245 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2008 | 44 | 0.020 |
Why?
|
| Goals | 1 | 2013 | 708 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3700 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2570 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 9648 | 0.020 |
Why?
|
| HIV Infections | 1 | 1994 | 17349 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2008 | 171 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 14607 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1281 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10203 | 0.020 |
Why?
|
| Food Additives | 1 | 1986 | 23 | 0.020 |
Why?
|
| Comorbidity | 2 | 2015 | 10514 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 2006 | 144 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2067 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2006 | 5879 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1986 | 173 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 163 | 0.020 |
Why?
|
| Differential Threshold | 1 | 2005 | 80 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2492 | 0.010 |
Why?
|
| Orbit | 1 | 2008 | 457 | 0.010 |
Why?
|
| Potassium Deficiency | 1 | 2004 | 9 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3419 | 0.010 |
Why?
|
| APACHE | 1 | 2004 | 267 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2017 | 6225 | 0.010 |
Why?
|
| Periodicity | 1 | 2005 | 347 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1336 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2010 | 961 | 0.010 |
Why?
|
| Nutrition Therapy | 1 | 2005 | 102 | 0.010 |
Why?
|
| Hypophosphatemia | 1 | 2004 | 92 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 3016 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 2004 | 204 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2004 | 226 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1997 | 2869 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 193 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 26068 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 3416 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2508 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2004 | 250 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2740 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 842 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 5993 | 0.010 |
Why?
|
| National Health Programs | 1 | 2006 | 440 | 0.010 |
Why?
|
| Vaccination | 1 | 1994 | 3368 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1995 | 793 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2005 | 268 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 781 | 0.010 |
Why?
|
| Renal Replacement Therapy | 1 | 2004 | 281 | 0.010 |
Why?
|
| Cebidae | 1 | 1981 | 21 | 0.010 |
Why?
|
| Muscle Hypertonia | 1 | 1981 | 12 | 0.010 |
Why?
|
| Survivors | 1 | 2012 | 2369 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2006 | 999 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7405 | 0.010 |
Why?
|
| Coronavirus | 1 | 2003 | 156 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1967 | 2256 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 1045 | 0.010 |
Why?
|
| Saimiri | 1 | 1981 | 333 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.010 |
Why?
|
| Craniotomy | 1 | 2005 | 741 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 763 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 815 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18217 | 0.010 |
Why?
|
| Seasons | 1 | 2005 | 1517 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2004 | 786 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 9001 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1138 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 976 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 3627 | 0.010 |
Why?
|
| Violence | 1 | 2004 | 935 | 0.010 |
Why?
|
| Walking | 1 | 2005 | 1194 | 0.010 |
Why?
|
| Alkalosis | 1 | 1997 | 55 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 1469 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1999 | 227 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3266 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 1782 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2004 | 1097 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1315 | 0.010 |
Why?
|
| Muscles | 1 | 1981 | 1567 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2004 | 1803 | 0.010 |
Why?
|
| Leucine | 1 | 1997 | 547 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1997 | 364 | 0.010 |
Why?
|
| Quisqualic Acid | 1 | 1995 | 35 | 0.010 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 70 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1995 | 39 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4111 | 0.010 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1999 | 326 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7804 | 0.010 |
Why?
|
| Potassium Cyanide | 1 | 1994 | 17 | 0.010 |
Why?
|
| Frozen Sections | 1 | 1995 | 153 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1837 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 659 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1986 | 3812 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1996 | 243 | 0.010 |
Why?
|
| Biopsy | 2 | 1996 | 6781 | 0.010 |
Why?
|
| Motor Cortex | 1 | 1981 | 1007 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1997 | 505 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3696 | 0.010 |
Why?
|
| Echocardiography | 1 | 1986 | 5006 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1996 | 970 | 0.010 |
Why?
|
| Heart Failure | 1 | 1997 | 11701 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1994 | 251 | 0.010 |
Why?
|
| Propidium | 1 | 1991 | 42 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 3307 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1351 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 495 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1097 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1996 | 402 | 0.010 |
Why?
|
| Anthropometry | 1 | 1996 | 1338 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 2571 | 0.010 |
Why?
|
| Communication | 1 | 2005 | 3852 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8519 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 1428 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1991 | 411 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 627 | 0.010 |
Why?
|
| Glycolysis | 1 | 1994 | 836 | 0.010 |
Why?
|
| Body Height | 1 | 1996 | 1565 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1995 | 589 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 858 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1986 | 4673 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 754 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 2420 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 5333 | 0.000 |
Why?
|
| Middle Aged | 4 | 2014 | 220835 | 0.000 |
Why?
|
| Cause of Death | 1 | 1998 | 3688 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1081 | 0.000 |
Why?
|
| Sodium Glutamate | 1 | 1986 | 23 | 0.000 |
Why?
|
| Naphthalenesulfonates | 1 | 1986 | 14 | 0.000 |
Why?
|
| Sensation | 1 | 1967 | 336 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1986 | 210 | 0.000 |
Why?
|
| Body Weight | 1 | 1996 | 4618 | 0.000 |
Why?
|
| Mouth | 1 | 1986 | 381 | 0.000 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1986 | 348 | 0.000 |
Why?
|
| Aged | 3 | 2004 | 169266 | 0.000 |
Why?
|
| Extremities | 1 | 1967 | 867 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 15308 | 0.000 |
Why?
|
| Cerebral Decortication | 1 | 1981 | 11 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13630 | 0.000 |
Why?
|
| Movement | 1 | 1967 | 1476 | 0.000 |
Why?
|
| Face | 1 | 1986 | 1025 | 0.000 |
Why?
|
| Meningioma | 1 | 1967 | 1216 | 0.000 |
Why?
|
| Food Hypersensitivity | 1 | 1986 | 726 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11505 | 0.000 |
Why?
|
| Electromyography | 1 | 1981 | 1393 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 58946 | 0.000 |
Why?
|